Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Definition of the Clinical Spectrum of Kernicterus and Bilirubin-Induced Neurologic Dysfunction (BIND)

Journal of Perinatology volume 25, pages 54–59 (2005)Cite this article

Abstract

Kernicterus, currently used to describe both the neuropathology of bilirubin-induced brain injury and its associated clinical findings, is a complex syndrome. The neurobiology of kernicterus, including the determinants and mechanisms of neuronal injury, is discussed along with traditional and evolving definitions ranging from classical kernicterus with athetoid cerebral palsy, impaired upward gaze and deafness, to isolated conditions, for example, auditory neuropathy or dys-synchrony (AN/AD), and subtle bilirubin-induced neurological dysfunction (BIND). The clinical expression of BIND varies with location, severity, and time of assessment, influenced by the amount, duration and developmental age of exposure to excessive free bilirubin. Although total serum bilirubin (TSB) is important, kernicterus cannot be defined based solely on TSB. For study purposes kernicterus may be defined in term and near-term infants with TSB ≄20 mg/dl using abnormal muscle tone on examination, auditory testing diagnostic of AN/AD, and magnetic resonance imaging showing bilateral lesions of globus pallidus±subthalamic nucleus.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Levine RL, Fredericks WR, Rapoport SI . Clearance of bilirubin from rat brain after reversible osmotic opening of the blood–brain barrier. Pediatr Res 1985;19(10):1040–1043.

    Article  CAS  Google Scholar 

  2. Ostrow JD, Pascolo L, Shapiro SM, Tiribelli C . New concepts of bilirubin encephalopathy. Eur J Clin Invest 2003;33(11):988–997.

    Article  CAS  Google Scholar 

  3. Ostrow JD, Pascolo L, Tiribelli C . Reassessment of the unbound concentrations of unconjugated bilirubin in relation to neurotoxicity in vitro. Pediatr Res 2003;54(1):98–104.

    Article  CAS  Google Scholar 

  4. Conlee JW, Shapiro SM . Development of cerebellar hypoplasia in jaundiced Gunn rats treated with sulfadimethoxine: a quantitative light microscopic analysis. Acta Neuropathol 1997;93:450–460.

    Article  CAS  Google Scholar 

  5. Churn SB, DeLorenzo RJ, Shapiro SM . Bilirubin induces a calcium-dependent inhibition of multifunctional Ca2+/calmodulin-dependent kinase II activity in vitro. Pediatr Res 1995;38:949–954.

    Article  CAS  Google Scholar 

  6. Conlee JW, Shapiro SM, Churn SB . Expression of the alpha and beta subunits of Ca2+/calmodulin kinase II in the cerebellum of jaundiced Gunn rats during development: a quantitative light microscopic analysis. Acta Neuropathol (Berl) 2000;99(4):393–401.

    Article  CAS  Google Scholar 

  7. Shaia WT, Shapiro SM, Heller AJ, Galiani DL, Sismanis A, Spencer RF . Immunohistochemical localization of calcium-binding proteins in the brainstem vestibular nuclei of the jaundiced Gunn rat. Hear Res 2002;173(1–2):82–90.

    Article  CAS  Google Scholar 

  8. Spencer RF, Shaia WT, Gleason AT, Sismanis A, Shapiro SM . Changes in calcium-binding protein expression in the auditory brainstem nuclei of the jaundiced Gunn rat. Hear Res 2002;171(1–2):129–141.

    Article  CAS  Google Scholar 

  9. Shapiro SM, Churn SB, Pal S, Limbrick DD, De Lorenzo RJ . Bilirubin alters intracellular calcium homeostasis. Pediatr Res 1998;42(42, Part 2):195A.

    Article  Google Scholar 

  10. Johnston MV, Hoon Jr AH . Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol 2000;15(9):588–591.

    Article  CAS  Google Scholar 

  11. Volpe JJ . Bilirubin and brain injury. In: Volpe JJ. editor. Neurology of the Newborn. Philadelphia: WB Saunders; 2001. p. 490–514.

    Google Scholar 

  12. Wennberg RP, Ahlfors CE, Bickers R, McMurtry CA, Shetter JL . Abnormal auditory brainstem response in a newborn infant with hyperbilirubinemia: improvement with exchange transfusion. J Pediatr 1982;100(4):624–626.

    Article  CAS  Google Scholar 

  13. Nwaesei CG, Van Aerde J, Boyden M, Perlman M . Changes in auditory brainstem responses in hyperbilirubinemic infants before and after exchange transfusion. Pediatr 1984;74(5):800–803.

    CAS  Google Scholar 

  14. Shapiro SM, Nakamura H . Bilirubin and the auditory system. J Perinatol 2001;21(Suppl 1):S52–S55 (discussion S59–62).

    Article  Google Scholar 

  15. Starr A, Picton TW, Sininger Y, Hood LJ, Berlin CI . Auditory neuropathy. Brain 1996;119(Part 3):741–753.

    Article  Google Scholar 

  16. Deltenre P, Mansbach AL, Bozet C, Clercx A, Hecox KE . Auditory neuropathy: a report on three cases with early onsets and major neonatal illnesses. Electroencephalogr Clin Neurophysiol 1997;104(1):17–22.

    Article  CAS  Google Scholar 

  17. Berlin CI, Bordelon J, St John P, et al. Reversing click polarity may uncover auditory neuropathy in infants. Ear Heart 1998;19(1):37–47.

    Article  CAS  Google Scholar 

  18. Berlin CI, Morlet T, Hood LJ . Auditory neuropathy/dyssynchrony: its diagnosis and management. Pediatr Clin North Am 2003;50(2:331–340 vii–viii.

    Article  Google Scholar 

  19. Chisin R, Perlman M, Sohmer H . Cochlear and brain stem responses in hearing loss following neonatal hyperbilirubinemia. Ann Otol 1979;88:352–357.

    CAS  Google Scholar 

  20. Volpe JJ . Bilirubin and brain injury. In: Volpe JJ. editor. Neurology of the Newborn. Philadelphia: WB Saunders Co; 1981. p. 336–356.

    Google Scholar 

  21. Hyman CB, Keaster J, Hanson V, et al. CNS abnormalities after neonatal hemolytic disease or hyperbilirubinemia. A prospective study of 405 patients. Am J Dis Child 1969;117:395–405.

    Article  CAS  Google Scholar 

  22. Johnson L, Boggs TR . Bilirubin-dependent brain damage: Incidence and indications for treatment. In: Odell GB, Schaffer R, Sionpoulous AP. editors. Phototherapy in the Newborn: An Overview 1974. Washington: National Academy of Sciences. p. 122–149.

    Google Scholar 

  23. Naeye RL . Amniotic fluid infections, neonatal hyperbilirubinemia and psychomotor impairment. Pediatr 1978;62:497–503.

    CAS  Google Scholar 

  24. Odell GB, Storey GN, Rosenberg LA . Studies in kernicterus III. The saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. J Pediatr 1970;76:12–21.

    Article  CAS  Google Scholar 

  25. Rubin RA, Balow B, Fisch RO . Neonatal serum bilirubin levels related to cognitive development at ages 4 through 7 years. J Pediatr 1979;94(4):601–604.

    Article  CAS  Google Scholar 

  26. Scheidt PC . Toxicity to bilirubin in neonates: infant development during first year in relation to maximal neonatal serum bilirubin concentration. J Pediatr 1977;92:292–297.

    Article  Google Scholar 

  27. Bergman I, Hirsch RP, Fria TJ, Shapiro SM, Holzman I, Painter MJ . Cause of hearing loss in the high-risk premature infant. J Pediatr 1985;106(1):5–101.

    Google Scholar 

  28. Salamy A, Eldredge L, Tooley WH . Neonatal status and hearing loss in high-risk infants. J Pediatr 1989;114(5):847–852.

    Article  CAS  Google Scholar 

  29. Rance G, Beer DE, Cone-Wesson B, et al. Clinical findings for a group of infants and young children with auditory neuropathy. Ear Heart 1999;20(3):238–252.

    Article  CAS  Google Scholar 

  30. Simmons JL, Beauchaine KL . Auditory neuropathy: case study with hyperbilirubinemia. J Am Acad Audiol 2000;11(6):337–347.

    CAS  PubMed  Google Scholar 

  31. de Vries LS, Lary S, Whitelaw AG, Dubowitz LM . Relationship of serum bilirubin levels and hearing impairment in newborn infants. Early Hum Dev 1987;15(5):269–277.

    Article  CAS  Google Scholar 

  32. de Vries LS, Lary S, Dubowitz LMS . Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk, low birth-weight infants. Pediatr 1985;76(3):351–354.

    CAS  Google Scholar 

  33. Seidman DS, Paz I, Stevenson DK, Laor A, Danon YL, Gale R . Neonatal hyperbilirubinemia and physical and cognitive performance at 17 years of age. Pediatr 1991;88(4):828–833.

    CAS  Google Scholar 

  34. Yilmaz Y, Degirmenci S, Akdas F, et al. Prognostic value of auditory brainstem response for neurologic outcome in patients with neonatal indirect hyperbilirubinemia. J Child Neurol 2001;16(10):772–775.

    Article  CAS  Google Scholar 

  35. Stein L, Tremblay K, Pasternak J, Banerjee S, Lindemann K . Auditory brainstem neuropathy and elevated bilirubin levels. Semin Hearing 1996;17:197–213.

    Article  Google Scholar 

  36. Shapiro SM, Rosen JR, Dixon KT . Auditory brainstem response (ABR) abnormalities and auditory neuropathy in children with kernicterus. Pediatr Res 2002;51(4 Part 2):340A.

    Google Scholar 

  37. Shapiro SM, Daymont MJ . Patterns of kernicterus related to neonatal hyperbilirubinemia and gestational age. Pediatr Res 2003;53(4 Part 2):398A–399A.

    Google Scholar 

  38. Shallop JK, Peterson A, Facer GW, Fabry LB, Driscoll CL . Cochlear implants in five cases of auditory neuropathy: postoperative findings and progress. Laryngoscope 2001;111(4 Part 1):555–562.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Child Neurology, Departments of Neurology and Pediatrics, Medical College of Virginia Campus, Virginia Commonwealth University Medical Center, Richmond, VA, USA

    Steven M Shapiro MD

Authors
  1. Steven M Shapiro MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shapiro, S. Definition of the Clinical Spectrum of Kernicterus and Bilirubin-Induced Neurologic Dysfunction (BIND). J Perinatol 25, 54–59 (2005). https://doi.org/10.1038/sj.jp.7211157

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211157

This article is cited by

Search

Advanced search

Quick links